Displaying One Session

Special Symposium

Targeting KRAS in lung cancer: Progress and next steps 

Session Track
NSCLC, metastatic
Chairs
  • Paul Baas (Amsterdam, Netherlands)
Release Date
Thu, 16.09.2021

Introduction 

Speakers
  • Paul Baas (Amsterdam, Netherlands)
Duration
5 Minutes

Current status of G12C inhibitors  

Speakers
  • Colin Lindsay (Manchester, United Kingdom)
Duration
15 Minutes

Mechanisms of resistance

Speakers
  • Piro Lito (New York City, United States of America)
Duration
15 Minutes

All things KRAS not G12C

Speakers
  • Chiara Ambrogio (Torino, Italy)
Duration
15 Minutes

Combinations including KRAS inhibitors

Speakers
  • Natasha Leighl (Toronto, Canada)
Duration
15 Minutes